Literature DB >> 7566342

Molecular dissection of the paired helical filament.

M Goedert1, M G Spillantini, R Jakes, R A Crowther, E Vanmechelen, A Probst, J Götz, K Bürki, P Cohen.   

Abstract

Abundant neurofibrillary tangles, neuropil threads and plaque neurites constitute the neurofibrillary pathology of Alzheimer's disease. They form in the nerve cells that undergo degeneration in the disease where their regional distribution correlates with the degree of dementia. Each lesion contains the paired helical filament (PHF) as its major fibrous component. Recent work has shown that PHFs are composed of the microtubule-associated protein tau in a hyperphosphorylated state. PHF-tau is hyperphosphorylated on six adult brain tau isoforms. As a consequence, tau is unable to bind to microtubules and is believed to self-assemble into the PHF. Current evidence suggests that protein kinases or protein phosphatases with a specificity for serine/threonine-proline residues play an important role in the hyperphosphorylation of tau. Candidate protein kinases include mitogen-activated protein kinase, glycogen synthase kinase-3 and cyclin-dependent kinase 5, whereas the trimeric form of protein phosphatase 2A is a candidate phosphatase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566342     DOI: 10.1016/0197-4580(95)00017-9

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  19 in total

1.  Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments.

Authors:  M E King; N Ghoshal; J S Wall; L I Binder; H Ksiezak-Reding
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  Phosphorylation of tau alters its association with the plasma membrane.

Authors:  F J Ekinci; T B Shea
Journal:  Cell Mol Neurobiol       Date:  2000-08       Impact factor: 5.046

Review 4.  Tau and axonopathy in neurodegenerative disorders.

Authors:  Makoto Higuchi; Virginia M Y Lee; John Q Trojanowski
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

5.  Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal.

Authors:  M Hetman; J E Cavanaugh; D Kimelman; Z Xia
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

Review 6.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 7.  Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease.

Authors:  Lezanne Ooi; Kuldip Sidhu; Anne Poljak; Greg Sutherland; Michael D O'Connor; Perminder Sachdev; Gerald Münch
Journal:  J Neural Transm (Vienna)       Date:  2012-06-13       Impact factor: 3.575

Review 8.  Tau function and dysfunction in neurons: its role in neurodegenerative disorders.

Authors:  Jesús Avila; Filip Lim; Francisco Moreno; Carlos Belmonte; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

9.  Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation.

Authors:  Linn Hege Nilsen; Caroline Rae; Lars M Ittner; Jürgen Götz; Ursula Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-23       Impact factor: 6.200

10.  Role for glyoxalase I in Alzheimer's disease.

Authors:  Feng Chen; M Axel Wollmer; Frederic Hoerndli; Gerald Münch; Björn Kuhla; Evgeny I Rogaev; Magdalini Tsolaki; Andreas Papassotiropoulos; Jürgen Götz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.